Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complications of systemic chemotherapy as treatment of retinoblastoma.

× No keyword cloud information.

27 in total

1. Effects of celecoxib in human retinoblastoma cell lines and in a transgenic murine model of retinoblastoma.

Authors: C T Tong; S A Howard; H R Shah; K R Van Quill; E T Lin; H E Grossniklaus; J M O'Brien
Journal: Br J Ophthalmol Date: 2005-09 Impact factor: 4.638

2. Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization.

Authors: M A Klufas; Y P Gobin; B Marr; S E Brodie; I J Dunkel; D H Abramson
Journal: AJNR Am J Neuroradiol Date: 2012-03-22 Impact factor: 3.825

3. Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors.

Authors: Samuel K Houston; Yolanda Pina; Jennifer Clarke; Tulay Koru-Sengul; William K Scott; Lubov Nathanson; Amy C Schefler; Timothy G Murray
Journal: Invest Ophthalmol Vis Sci Date: 2011-07-23 Impact factor: 4.799

4. Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.

Authors: Sofia Theodoropoulou; Paraskevi E Kolovou; Yuki Morizane; Maki Kayama; Fotini Nicolaou; Joan W Miller; Evangelos Gragoudas; Bruce R Ksander; Demetrios G Vavvas
Journal: FASEB J Date: 2010-04-06 Impact factor: 5.191

5. Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.

Authors: Nermeen S Youssef; Azza M Said
Journal: Int J Clin Exp Pathol Date: 2014-08-15

6. Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma.

Authors: Shin J Kang; Chandrasekar Durairaj; Uday B Kompella; Joan M O'Brien; Hans E Grossniklaus
Journal: Arch Ophthalmol Date: 2009-08

7. Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma.

Authors: Yolanda Piña; Samuel K Houston; Timothy G Murray; Hinda Boutrid; Magda Celdran; William Feuer; Wei Shi; Eleut Hernandez; Theodore J Lampidis
Journal: Invest Ophthalmol Vis Sci Date: 2010-08-11 Impact factor: 4.799

8. Treatment with connexin 46 siRNA suppresses the growth of human Y79 retinoblastoma cell xenografts in vivo.

Authors: Diana B Burr; Samuel A Molina; Debarshi Banerjee; Derek M Low; Dolores J Takemoto
Journal: Exp Eye Res Date: 2011-02-12 Impact factor: 3.467

9. Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway.

Authors: Pina Fortunato; Serena Pillozzi; Angela Tamburini; Liliana Pollazzi; Alessandro Franchi; Agostino La Torre; Annarosa Arcangeli
Journal: BMC Cancer Date: 2010-09-22 Impact factor: 4.430

10. Revisiting old drugs as novel agents for retinoblastoma: in vitro and in vivo antitumor activity of cardenolides.

Authors: Christophe Antczak; Carolyn Kloepping; Constantin Radu; Thorsten Genski; Lutz Müller-Kuhrt; Karsten Siems; Elisa de Stanchina; David H Abramson; Hakim Djaballah
Journal: Invest Ophthalmol Vis Sci Date: 2009-01-17 Impact factor: 4.799